Abstract
Background
The COVID-19 pandemic has progressed rapidly, with the emergence of new virus variants that pose challenges in treating infected individuals. In Mexico, four epidemic waves have been recorded with varying disease severity. To understand the heterogeneity in clinical presentation over time and the sensitivity and specificity of signs and symptoms in identifying COVID-19 cases, an analysis of the changes in the clinical presentation of the disease was conducted.
Aim
To analyze the changes in the clinical presentation of COVID-19 among 3.38 million individuals tested for SARS-CoV-2 at the Mexican Social Security Institute (IMSS) from March 2020 to October 2021 and evaluate the predictivity of signs and symptoms in identifying COVID-19 cases.
Methods
A retrospective analysis of clinical presentation patterns of COVID-19 among individuals treated at IMSS was performed, contrasting the signs and symptoms among SARS-CoV-2-positive individuals with those who tested negative for the virus but had respiratory infection symptoms. The sensitivity and specificity of each sign and symptom in identifying SARS-CoV-2 infection were estimated.
Results
The set of signs and symptoms reported for COVID-19-suspected patients treated at IMSS were not highly specific for SARS-CoV-2 positivity. The signs and symptoms exhibited variability based on age and epidemic wave. The area under the receiver operating characteristic (ROC) curve was 0.62 when grouping the five main symptoms (headache, dyspnea, fever, arthralgia, and cough). Most of the individual symptoms had ROC values close to 0.5 (16 out of 22 between 0.48 and 0.52), indicating non-specificity.
Conclusions
The results highlight the difficulty in making a clinical diagnosis of COVID-19 due to the lack of specificity of signs and symptoms. The variability of clinical presentation over time and among age groups highlights the need for further research to differentiate whether the changes are due to changes in the virus, who is becoming infected, or the population, particularly with respect to prior infection and vaccination status.
Funder
C3.ai Digital Transformation Institute
Publisher
Public Library of Science (PLoS)
Reference22 articles.
1. Estimación del exceso de mortalidad por todas las causas durante la pandemia del Covid-19 en México.;LS Palacio Mejía;Salud Pública de México.,2021
2. Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). StatPearls;A Aleem;Treasure Island (FL): StatPearls Publishing,2022
3. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.;L Forchette;Curr Med Sci.,2021
4. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.;DA Wohl;PLOS ONE,2021
5. COVID-19 in the Mexican Social Security Institute (IMSS) population. Prevalent symptoms;A Juárez-Flores;medRxiv,2022